A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation.
D000208:Acute Disease; D000328:Adult; D000510:Alpha-Globulins / Q000032:analysis*; D000990:Antithrombin III / Q000032:analysis*; D001780:Blood Coagulation Tests / Q000379:methods*; D002908:Chronic Disease; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000188:drug therapy; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007118:Immunoassay; D008113:Liver Neoplasms / Q000097:blood; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000097:blood; D012044:Regression Analysis; D013927:Thrombosis / Q000097:blood
D000510:Alpha-Globulins; D005338:Fibrin Fibrinogen Degradation Products; D000990:Antithrombin III; D006493:Heparin